87 companies revolutionizing healthcare data interoperability
From patient data exchanges to developer toolkits, these vendors are working across tech markets to make healthcare data more accessible.
From patient data exchanges to developer toolkits, these vendors are working across tech markets to make healthcare data more accessible.
From real-world data to digital therapeutics, this MVP Technology Framework evaluates the tech solutions pharmaceutical companies and contract research organizations (CROs) like Pfizer and IQVIA are using to develop and deliver personalized medicine.
This report looks at the companies helping pharmaceutical companies and contract research organizations (CROs) discover new drugs.
We mined Microsoft's acquisitions, investments, and partnerships to discern the company's strategic priorities.
We dive into the evolution of clinical trials and where the space is going next, from AI to improve recruitment to in silico trials with simulated patients.
Curebase plans to use the funds to move further into the pharma and biotech spaces. Here are the top-line bullets you need to know.
The company was last valued at $2.2B in August 2021. Here are the top-line bullets you need to know.
Mendel.ai plans to use the funds to accelerate the launch of its clinical information consolidation tool. Here are the top-line bullets you need to know.
This news comes on the heels of its Series I round. The funding will help DNAnexus support product development and international growth. Here are the top-line bullets you need to know.
Terray Therapeutics plans to use the funds to advance its preclinical therapeutics pipeline and its proprietary tNova platform. Here are the top-line bullets you need to know.
This report uses the CB Insights MVP Technology Framework to rank tech market planning decisions and give an adoption playbook for the clinical trials domain.
The Series F round brings Benchling's total funding to $412M. Here are the top-line bullets you need to know.
Owkin has raised $254.1M in funding to date. Here are the top-line bullets you need to know.
The funding will be used to quadruple its team by Q1'22. Here are the top-line bullets you need to know.
The funding will help Qualio triple its headcount. Here are the top-line bullets you need to know.
The company has raised $212M to date for its real world evidence platform. Here are the top-line bullets you need to know.
Benchling attained unicorn status at a $4B valuation amid its IPO preparations. Here are the top-line bullets you need to know.
Our healthcare report provides a data-driven look at global healthcare technology investment trends, top deals, active investors, and corporate activity.
Covid-19 has propelled digital health into the mainstream. From telehealth to clinical intelligence to AI-enabled drug discovery, these Canada-based startups stand to benefit in a post-Covid world.
Smartphones have the potential to hugely increase access to pathogen detection — a critical step in diagnosing and preventing the spread of infectious diseases.
Market Map
From molecular diagnostics to disinfecting robots, these 40+ startups are looking to change how infectious diseases are prevented, diagnosed, treated, and managed.
Our interns used the CB Insights platform to analyze emerging trends in computing, DNA data storage, aviation, and more.
On the cusp of a genomics revolution, securing our genetic data is becoming more important than ever. We dig into rising threats and emerging solutions around protecting our most valuable personal data — our DNA.
After being accused of years of fraud, Theranos officially shut down in September 2018. But in March of this year — and just a few months after its death — the company was granted its first blood-testing patent of 2019. Since then, Theranos has been granted 4 additional patents.
Advances in industrial biochemistry have unlocked the potential to harness small cells to make fuel, foods, and custom materials. We looked at startups using cells for factory-scale production.